Breast Cancer: New Horizons, Current Controversies is organized by Harvard Medical School (HMS) and will be held from Jul 11 – 13, 2019 at Boston Marriott Long Wharf, Boston, Massachusetts, United States of America.
Target Audience:
This course is targeted to physicians, nurses, nurse practitioners, and physician assistants who practice in family medicine, internal medicine, medical genetics and genomics, oncology and hematology, plastic surgery, radiology, and/or surgery.
Accreditation:
Physicians
The Harvard Medical School designates this live activity for a maximum of 20.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Risk Management
This activity meets the criteria of the Massachusetts Board of Registration in Medicine for 0.50 credits of Risk Management Study. This includes:
• 0.50 Credits of End-of-Life Care Studies
Registered Nurses
Dana-Farber Cancer Institute is an approved provider of continuing nursing education by the American Nurses Association Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses should claim only the credit commensurate with the extent of their participation in the activity. A maximum of 20.50 Contact Hours will be awarded upon completion of an evaluation.
Course Description:
Breast Cancer: New Horizons, Current Controversies is a comprehensive educational curriculum – now in its 18th year of improving the knowledge, competence, and clinical skills of medical, surgical, and radiation oncologists; breast and general surgeons; internal medicine specialists; physician assistants, nurse practitioners, and oncology nurses; and other clinicians involved in the care of women with breast cancer.
The primary goal of Breast Cancer: New Horizons, Current Controversies is to assist health care professionals with integrating evidence-based information on breast cancer screening, diagnosis, treatment, and long-term monitoring into their practices. This interactive, engaging, three-day course is taught by clinical experts in medical, surgical, and radiation oncology, who take a multidisciplinary approach to translating scientific knowledge into practical applications for patient care. Interactive learning formats, including group case discussions, question and answer periods (Q&A), and panel presentations, assist clinicians in solving challenging clinical cases, addressing controversial topics, and developing practical treatment strategies.
Learning Objectives:
Upon completion of this activity, participants will be able to:
- Discuss recent, clinical data and current, expert recommendations to patient selection for new and emerging therapies for advanced and triple-negative breast cancer;
- Recognize the molecular heterogeneity of breast cancer and therapeutic implications for HER2+ and ER+, and metastatic disease;
- Identify the challenges in the treatment of breast cancer in special populations including the elderly and men and how treatment affects women who are pregnant and adjust treatment decisions for specific patients;
- Summarize recent, clinical data and expert recommendations to the management of women with breast cancer who are treated with mastectomy, including integration of surgical methods, breast reconstruction options, and post-mastectomy radiation;
- Assess current practices with regard to symptom management during active breast cancer treatment and in survivorship, consider needs for fertility and lifestyle counseling among patients with breast cancer and survivors, and improve current practices;
• Recognize areas of breast cancer management, including diagnostics and staging, imaging, and multimodal management, where recent evidence has changed the clinical practice paradigm, and make appropriately individualized changes in patient management.
Registration Desk
| Contact No. : | (617) 384-8600 |
| Email: |
